NASDAQ:OACC Oaktree Acquisition Corp. III Life Sciences (OACC) Stock Price, News & Analysis $10.74 +0.13 (+1.23%) Closing price 05/8/2026 03:58 PM EasternExtended Trading$10.60 -0.14 (-1.34%) As of 05/8/2026 04:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Oaktree Acquisition Corp. III Life Sciences Stock (NASDAQ:OACC) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get OACC alerts:Sign Up Key Stats Today's Range$10.61▼$10.6250-Day Range$10.57▼$10.7052-Week Range$10.30▼$10.74Volume1,614 shsAverage Volume4,254 shsMarket Capitalization$263.99 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACC) is a special purpose acquisition company (“SPAC”) formed to pursue merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combinations with one or more businesses in the life sciences sector. Incorporated as a Cayman Islands exempted company, OACC is sponsored by Oaktree Capital Management, a global alternative investment firm with a longstanding track record in credit strategies and private equity. The SPAC structure provides a pool of cash and public equity to support target companies in biopharmaceuticals, medical devices, diagnostics and other related segments of the life sciences industry. Since completing its initial public offering in December 2020, OACC has been actively evaluating potential targets worldwide, with a primary focus on North America and Europe. The company’s search criteria emphasize businesses with innovative product pipelines, scalable platforms and strong management teams capable of addressing significant unmet medical needs. OACC’s board and management team draw on Oaktree Capital’s deep industry expertise and global network to assess opportunities, structure transactions and support acquired companies through post-closing integration. Governance and oversight are provided by a board of directors and executive officers that include senior professionals affiliated with Oaktree Capital Management. Leveraging the sponsor’s rigorous due-diligence framework and operational support, OACC seeks to deliver long-term value for public shareholders by combining financial discipline with strategic guidance tailored to life sciences enterprises. The SPAC format offers target companies a streamlined path to public markets, enhanced visibility and access to growth capital under the oversight of an experienced sponsor.AI Generated. May Contain Errors. Read More Receive OACC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Oaktree Acquisition Corp. III Life Sciences and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. OACC Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com OACC Stock Analysis - Frequently Asked Questions How have OACC shares performed this year? Oaktree Acquisition Corp. III Life Sciences' stock was trading at $10.58 at the beginning of the year. Since then, OACC shares have increased by 1.5% and is now trading at $10.74. How were Oaktree Acquisition Corp. III Life Sciences' earnings last quarter? Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) released its earnings results on Thursday, March, 26th. The company reported $0.08 earnings per share (EPS) for the quarter. How do I buy shares of Oaktree Acquisition Corp. III Life Sciences? Shares of OACC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings3/26/2026Today5/09/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (4m+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 OACC's financial health is in the Green zone, according to TradeSmith. OACC has been in this zone for over 4 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorFinancial Services Industry Investment Offices Sub-IndustryTrading Current SymbolNASDAQ:OACC CIK2029769 WebN/A Phone(213) 830-6300FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares24,580,000Free FloatN/AMarket Cap$263.99 million OptionableN/A Beta-0.02 (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free Report This page (NASDAQ:OACC) was last updated on 5/9/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)A little-known stock pick with money-doubling potential over the next year is revealed for free in the first t...Paradigm Press | SponsoredYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredTrade this between 9:30 and 10:45 am ESTThe first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...Base Camp Trading | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredInvest in SpaceX Before IPOSpaceX is already one of the most valuable private companies on Earth, and some analysts believe its valuation...NXT Wave Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oaktree Acquisition Corp. III Life Sciences Please log in to your account or sign up in order to add this asset to your watchlist. Share Oaktree Acquisition Corp. III Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.